SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-216507
Filing Date
2017-06-28
Accepted
2017-06-28 16:17:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d408841d424b5.htm 424B5 254946
2 GRAPHIC g408841g56l71.jpg GRAPHIC 21299
  Complete submission text file 0001193125-17-216507.txt   285388
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211175 | Film No.: 17935418
SIC: 2834 Pharmaceutical Preparations